Pneumonia

At a glance

  • Pneumonia is usually caused by bacteria or viruses.
  • The typical symptoms of pneumonia are a high fever, a cough and feeling weak.
  • If it is caused by bacteria, it is typically treated with antibiotics.
  • Washing your hands frequently and paying attention to good hygiene can prevent infection.
  • Complications are more common in babies, in older age, and in people who also have certain other medical conditions.
  • Vaccinations are recommended for people who have a higher risk.

Introduction

Photo of man with scarf and cup, coughing

People who develop often feel very ill quite suddenly: They may have a high fever, chills, a cough and get out of breath easily. This happens because small air sacs () in their lungs are inflamed, along with the surrounding lung tissue.

Pneumonia is often caused by . It can then usually be successfully treated with . There are also vaccinations that can prevent that's caused by certain germs.

People who are otherwise in good health generally recover within a few weeks. But shouldn't be taken too lightly: It can take several months to get back to full strength.

Pneumonia may sometimes lead to life-threatening complications, especially if you have already been weakened by another illness. It can also be dangerous in babies and in older age.

This simplified anatomical illustration shows pneumonia in the left lung. On the right side of the illustration there is a detailed view of healthy and inflamed alveoli.

Symptoms

The typical signs of are:

  • High fever and chills
  • Feeling weak and very unwell
  • Cough with phlegm
  • Shortness of breath and rapid breathing
  • Racing pulse

The symptoms don't always all occur at the same time. Particularly children and older people may not have certain typical symptoms. Or other, less typical symptoms such as diarrhea, stomach pain or drowsiness and confusion might be more noticeable.

Causes

Pneumonia is often caused by bacteria. Which kind of generally depends on where you become infected: If you get at home, it is likely to be caused by called pneumococci. If you develop in the hospital, it is often caused by other that are harder to treat.

It can also be caused by viruses or (in rarer cases) fungal infections. Sometimes is caused by things other than germs – such as radiation, inhaled poisonous substances, an allergic reaction or circulation problems in the lungs.

Risk factors

The risk of developing is particularly high in babies and older people (over 65 years).

Other risk factors include:

Sometimes germs from the mouth and throat, bits of food or stomach contents can get into the airways and lead to . This is known as aspiration . The risk is especially high in people who are bedridden, confused, or have trouble swallowing due to dementia or stroke, for instance.

Some medications are also thought to possibly increase the risk of , such as drugs that reduce the level of acid in the stomach. But it's still not clear whether they actually have this effect.

Prevalence

Over 500,000 people develop each year in Germany, and about 250,000 of them need treatment in hospital. A total of 20,000 people die of per year – especially older people over 65 and people who have been weakened by other diseases. That makes it one of the top ten causes of death in Germany.

Pneumonia is even more common in poorer countries, where babies and children are most often affected.

Outlook

The typical signs of are a sudden high fever and chills. People with start to feel very ill within just a few hours. Symptoms such as a cough with phlegm and shortness of breath are also typical. But it may also develop gradually and start with few or only mild symptoms, particularly in older people.

Left untreated, the fever lasts for about one week. Your body temperature then goes back down to normal levels. This may be accompanied by profuse sweating. The blood vessels in the skin also become wider so that the body can give off excess heat. That can put a lot of strain on the heart and circulation of someone who is already weak. So complications are common during this phase of the illness.

Once this phase has passed, your general wellbeing gradually improves and the usually goes away completely after about four weeks. But you may still feel run-down and tired for some time, and the cough may also last quite a while.

Pneumonia rarely becomes this serious nowadays, though, because it's usually treated immediately. Taking usually makes the fever go away more quickly, and helps you to feel better faster. But it's still important not to start doing too much too soon after having . Otherwise, it may come back or lead to other complications.

Effects

Pneumonia can cause the membrane that covers the lungs (the pleura) to become inflamed. That results in severe pain when you cough or breathe. Fluid may also collect between the lungs and the chest wall, making it even harder to breathe. Another possible complication is a lung abscess (a pus-filled space in the lung).

Pneumonia can sometimes lead to life-threatening complications, too – such as heart rhythm problems, circulatory collapse, respiratory or heart failure, or blood poisoning (sepsis). The risk of complications is greater if you

Diagnosis

Pneumonia can often be diagnosed based on typical symptoms. In a physical examination, the doctor mainly listens carefully to your lungs using a stethoscope and measures your pulse and blood pressure.

An x-ray of the lungs is usually taken, too. The x-ray images can show where (and how much of) the lung tissue is inflamed. A more involved type of x-ray exam, known as a CT scan, is sometimes needed. Changes to the outer edges of the lungs can also be seen using ultrasound.

Blood is taken as well, to measure things like the level of . Because the infected lungs are no longer working properly, doctors may need to check how much oxygen is in the blood. That can be done without taking blood, using a technique known as pulse oximetry. This involves placing a clip-like device on one of your fingers. The oxygen content is measured using a light sensor on the device.

Blood, urine and coughed-up mucus (phlegm) can be tested in a laboratory to find out exactly which germs are causing the .

Prevention

The best way to prevent respiratory infections is by practicing good personal hygiene, including regularly washing your hands and keeping your distance from others.

People who have an increased risk of or complications are advised to have vaccines too. For example, children can be vaccinated against Hemophilus influenzae and pneumococcal . People over the age of 60 are advised to have the flu vaccine and the pneumococcal vaccine.

Herbal medicines and dietary supplements such as vitamin products are often said to strengthen the . But no studies have proven that they have any worthwhile benefits – except in people who have a diagnosed vitamin deficiency. That is rare in Germany and similar countries nowadays, and generally only occurs in people who have a very unbalanced diet.

Treatment

If is caused by , it is generally treated with antibiotics. The most suitable type of will depend on the type of .

The treatment with lasts about 5 to 7 days. They can be taken in the form of tablets or a syrup. Depending on the severity of the illness and the risk of complications, treatment in a hospital may sometimes be needed. The are usually given as an infusion (drip) there.

People with severe may be given a steroid injection too. Sometimes extra oxygen is given through a mask; artificial respiration is less commonly needed.

If the was caused by viruses such as flu viruses or the coronavirus SARS-CoV-2, other medications known as antiviral drugs may be used. These specifically target viruses. Antibiotics are also used in viral , though, with the aim of preventing a bacterial from developing too.

Cough medicines from the pharmacy, special breathing exercises and physical therapy aren't recommended for the treatment of .

Further information

When people are ill or need medical advice, they usually go to see their family doctor first. Information about health care in Germany can help you to navigate the German healthcare system and find a suitable doctor. You can use this list of questions to prepare for your appointment.

Almirall J, Serra-Prat M, Bolíbar I et al. Risk Factors for Community-Acquired Pneumonia in Adults: A Systematic Review of Observational Studies. Respiration 2017; 94(3): 299-311.

Baskaran V, Murray RL, Hunter A et al. Effect of tobacco smoking on the risk of developing community acquired pneumonia: A systematic review and meta-analysis. PLoS One 2019; 14(7): e0220204.

Briel M, Spoorenberg SM, Snijders D et al. Corticosteroids in Patients Hospitalized With Community-Acquired Pneumonia: Systematic Review and Individual Patient Data Metaanalysis. Clin Infect Dis 2018; 66(3): 346-354.

Chang CC, Cheng AC, Chang AB. Over-the-counter (OTC) medications to reduce cough as an adjunct to antibiotics for acute pneumonia in children and adults. Cochrane Database Syst Rev 2014; (3): CD006088.

Chaves GS, Freitas DA, Santino TA et al. Chest physiotherapy for pneumonia in children. Cochrane Database Syst Rev 2019; (1): CD010277.

Chen X, Jiang J, Wang R et al. Chest physiotherapy for pneumonia in adults. Cochrane Database Syst Rev 2022; (9): CD006338.

Das RR, Singh M, Naik SS. Vitamin D as an adjunct to antibiotics for the treatment of acute childhood pneumonia. Cochrane Database Syst Rev 2023; 1(1): CD011597.

Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin (DGP). S3-Leitlinie Behandlung von erwachsenen Patienten mit ambulant erworbener Pneumonie (in Überarbeitung). AWMF register no.: 020-020. 2021.

Eppinger M, Müller M. Pädiatrie für Studium und Praxis. Breisach: Medizinische Verlags- und Informationsdienste; 2023.

Gesellschaft für Pädiatrische Pneumologie (GPP), Deutsche Gesellschaft für Pädiatrische Infektiologie (DGPI). S2k-Leitlinie Management der ambulant erworbenen Pneumonie bei Kindern und Jugendlichen (pCAP). AWMF register no.: 048-013. 2024.

Herold G. Innere Medizin. Cologne: Selbstverlag; 2025.

Horita N, Otsuka T, Haranaga S et al. Adjunctive Systemic Corticosteroids for Hospitalized Community-Acquired Pneumonia: Systematic Review and Meta-Analysis 2015 Update. Sci Rep 2015; 5: 14061.

Huang J, Guo J, Li H et al. Efficacy and safety of adjunctive corticosteroids therapy for patients with severe community-acquired pneumonia: A systematic review and meta-analysis. Medicine (Baltimore) 2019; 98(13): e14636.

Institute for Quality and Efficiency in Health Care (IQWiG, Germany). Antibiotikatherapie: Führt eine verkürzte Einahmedauer zu vergleichbaren Behandlungsergebnissen? ThemenCheck report commissioned by IQWiG; T23-04. 2025.

Jiang S, Liu T, Hu Y et al. Efficacy and safety of glucocorticoids in the treatment of severe community-acquired pneumonia: A meta-analysis. Medicine (Baltimore) 2019; 98(26): e16239.

Kasper DL, Fauci AS, Hauser SL et al. Harrison's Principles of Internal Medicine. New York: McGraw-Hill; 2015.

Lambert AA, Lam JO, Paik JJ et al. Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: a systematic review and meta-analysis. PLoS One 2015; 10(6): e0128004.

Larsen T, Lee A, Brooks D et al. Effect of Early Mobility as a Physiotherapy Treatment for Pneumonia: A Systematic Review and Meta-Analysis. Physiother Can 2019; 71(1): 82-89.

Lux LJ, Posey RE, Daniels LS et al. Pharmacokinetic/Pharmacodynamic Measures for Guiding Antibiotic Treatment for Hospital-Acquired Pneumonia. (AHRQ Comparative Effectiveness Reviews; No. 136). 2014.

Marti C, Grosgurin O, Harbarth S et al. Adjunctive Corticotherapy for Community Acquired Pneumonia: A Systematic Review and Meta-Analysis. PLoS One 2015; 10(12): e0144032.

National Institute for Health and Care Excellence (NICE). Suspected acute respiratory infection in over 16s: assessment at first presentation and initial management (NICE Clinical Guidelines; No. 237). 2025.

Nguyen PA, Islam M, Galvin CJ et al. Meta-analysis of proton pump inhibitors induced risk of community-acquired pneumonia. Int J Qual Health Care 2020; 32(5): 292-299.

Padhani ZA, Moazzam Z, Ashraf A et al. Vitamin C supplementation for prevention and treatment of pneumonia. Cochrane Database Syst Rev 2021; (11): CD013134.

Prina E, Ranzani OT, Torres A. Community-acquired pneumonia. Lancet 2015; 386(9998): 1097-1108.

Robert Koch-Institut (RKI). Antworten auf häufig gestellte Fragen (FAQ) zu akuten Atemwegserkrankungen und COVID-19. 2025.

Robert Koch-Institut (RKI). Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut 2020/2021. Epidemiologisches Bulletin 2020; 34: 4-60.

Siemieniuk RA, Meade MO, Alonso-Coello P et al. Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia: A Systematic Review and Meta-analysis. Ann Intern Med 2015; 163(7): 519-528.

Smit JM, Van Der Zee PA, Stoof SCM et al. Predicting benefit from adjuvant therapy with corticosteroids in community-acquired pneumonia: a data-driven analysis of randomised trials. Lancet Respir Med 2025; 13(3): 221-233.

Statistisches Bundesamt (Destatis). Todesursachen. 2025.

Stern A, Skalsky K, Avni T et al. Corticosteroids for pneumonia. Cochrane Database Syst Rev 2017; (12): CD007720.

Weltgesundheitsorganisation (WHO). Pneumonia in children. 2022.

Yakoob MY, Salam RA, Khan FR et al. Vitamin D supplementation for preventing infections in children under five years of age. Cochrane Database Syst Rev 2016; (11): CD008824.

Zhou YF, Luo BA, Qin LL. The association between vitamin D deficiency and community-acquired pneumonia: A meta-analysis of observational studies. Medicine 2019; 98(38): e17252.

IQWiG health information is written with the aim of helping people understand the advantages and disadvantages of the main treatment options and health care services.

Because IQWiG is a German institute, some of the information provided here is specific to the German health care system. The suitability of any of the described options in an individual case can be determined by talking to a doctor. informedhealth.org can provide support for talks with doctors and other medical professionals, but cannot replace them. We do not offer individual consultations.

Our information is based on the results of good-quality studies. It is written by a team of health care professionals, scientists and editors, and reviewed by external experts. You can find a detailed description of how our health information is produced and updated in our methods.

Comment on this page

What would you like to share with us?

We welcome any feedback and ideas - either via our form or by gi-kontakt@iqwig.de. We will review, but not publish, your ratings and comments. Your information will of course be treated confidentially. Fields marked with an asterisk (*) are required fields.

Please note that we do not provide individual advice on matters of health. You can read about where to find help and support in Germany in our information “How can I find self-help groups and information centers?

Print page

Über diese Seite

Updated on January 14, 2026

Next planned update: 2029

Publisher:

Institute for Quality and Efficiency in Health Care (IQWiG, Germany)

Stay informed

Subscribe to our newsletter or newsfeed. You can find our growing collection of films on YouTube.